Based on these results, we decided to divide the analysed group into two subgroups of different prognosis: (1) women with tumours characterized by low TOPOαLI and high MVD and BCL-2 positivity (n = 18) and (2) the remaining patients (n = 153). Here, BCL2 is linked to neoplasm.